Multiple Sclerosis Progression Discussion Tool Usability and Usefulness in Clinical Practice: Cross-sectional, Web-Based Survey

Tjalf Ziemssen   ¹ , MD ;   Gavin Giovannoni   ² , MBBCHIR, PhD ;   Enrique Alvarez   ³ , MD ;   Virender Bhan   ⁴ , MD ;   Carrie Hersh   ⁵ , DO, MS ;   Olaf Hoffmann   ⁶ , MD, PhD ;   Celia Oreja-Guevara   ⁷ , MD ;   Rene R Robles-Cedeño   ⁸ , MD, PhD ;   Maria Trojano   ⁹ , MD ;   Patrick Vermersch   ¹⁰ , MD, PhD ;   Pamela Dobay   ¹¹ , PhD ;   Mudeer Khwaja   ¹² , BSc ;   Bianca Stadler   ¹² , PhD ;   Benedict Rauser   ¹² , PhD ;   Thomas Hach   ¹² , MD ;   Daniela Piani-Meier   ¹² , PhD ;   Jason Burton   ¹³ , MD

¹ Center of Clinical Neuroscience, Neurological University Clinic Carl-Gustav Carus, Dresden, Germany

² Blizard Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom

³ University of Colorado School of Medicine, Aurora, CO, United States

⁴ University of British Columbia, Vancouver, BC, Canada

⁵ Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, NV, United States

⁶ Department of Neurology, St Josefs-Krankenhaus, Potsdam, Germany

⁷ Department of Neurology, Hospital Clínico San Carlos, Madrid, Spain

⁸ Department of Neurology, Girona Neuroimmunology & Multiple Sclerosis Unit, Dr. Josep Trueta University Hospital & Santa Caterina Hospital, Girona, Spain

⁹ Department of Basic Medical Sciences, Neuroscience and Sense Organs, University of Bari, Bari, Italy

¹⁰ University of Lille, INSERM U1172, Lille Neuroscience and Cognition, CHU Lille, FHU Precise, Lille, France

¹¹ Real World Evidence Solutions, IQVIA AG, Basel, Switzerland

¹² Novartis Pharma AG, Basel, Switzerland

¹³ Centre for Neuromuscular and Neurological Disorders, Western Australian Neuroscience Research Institute, The University of Western Australia, Perth, Australia